18 Recruiting Glioma Phase 1 Clinical Trials
Active phase 1 studies for glioma enrolling across the USA. Verify eligibility and contact site coordinators.
All Glioma studiesPhase 1 Studies for Glioma
Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Multiparametric Metabolic and Hypoxic PET/MRI Imaging Substudy in Gliomas
📍 UAB — Birmingham, Alabama
View Study & Checklist ➔Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas
📍 Rosy Njonkou Tchoquessi — Baltimore, Maryland
View Study & Checklist ➔Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔A Study of 177Lu-PSMA-617 in People With Gliomas
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
📍 Northshore University Hospital — Manhasset, New York
View Study & Checklist ➔Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
📍 The Cancer Therapy and Research Center at UTHSCSA — San Antonio, Texas
View Study & Checklist ➔PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
📍 Mayo Clinic — Rochester, Minnesota
View Study & Checklist ➔Hyperpolarized Imaging in Diagnosing Participants With Glioma
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔18F-Fluciclovine PET-MRI in High-grade Glioma
📍 Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
📍 The Children s Hospital of Philadelphia — Philadelphia, Pennsylvania
View Study & Checklist ➔A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
📍 University of California Irvine — Orange, California
View Study & Checklist ➔Sitagliptin in Recurrent/Progressive Grade 4 Glioma
📍 University of Iowa Health Care — Iowa City, Iowa
View Study & Checklist ➔